{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:18:32Z","timestamp":1791389912237,"version":"4.3.3"},"reference-count":30,"publisher":"Rockefeller University Press","issue":"8","content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,8,3]]},"abstract":"<jats:p>Ro52\/Trim21 is targeted as an autoantigen in systemic lupus erythematosus and Sj\u00f6gren's syndrome. Polymorphisms in the Ro52 gene have been linked to these autoimmune conditions, but the molecular mechanism by which Ro52 may promote development of systemic autoimmune diseases has not been explored. To address this issue, we generated Ro52-null mice (Ro52\u2212\/\u2212), which appear phenotypically normal if left unmanipulated. However, Ro52\u2212\/\u2212 mice develop severe dermatitis extending from the site of tissue injury induced by ear tags. The affected mice further develop several signs of systemic lupus with hypergammaglobulinemia, autoantibodies to DNA, proteinuria, and kidney pathology. Ro52, which was recently identified as an E3 ligase, mediates ubiquitination of several members of the interferon regulatory factor (IRF) family, and the Ro52-deficient mice have an enhanced production of proinflammatory cytokines that are regulated by the IRF transcription factors, including cytokines involved in the Th17 pathway (interleukin [IL] 6, IL-12\/IL-23p40, and IL-17). Loss of IL-23\/IL-17 by genetic deletion of IL-23\/p19 in the Ro52\u2212\/\u2212 mice conferred protection from skin disease and systemic autoimmunity. These data reveal that the lupus-associated Ro52 protein is an important negative regulator of proinflammatory cytokine production, and they provide a mechanism by which a defective Ro52 function can lead to tissue inflammation and systemic autoimmunity through the IL-23\u2013Th17 pathway.<\/jats:p>","DOI":"10.1084\/jem.20090585","type":"journal-article","created":{"date-parts":[[2009,7,27]],"date-time":"2009-07-27T21:30:13Z","timestamp":1248730213000},"page":"1661-1671","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":283,"title":["Loss of the lupus autoantigen Ro52\/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23\u2013Th17 pathway"],"prefix":"10.1084","volume":"206","author":[{"given":"Alexander","family":"Espinosa","sequence":"first","affiliation":[{"name":"Department of Medicine 1 , 2 , and 3"},{"name":"Department of Oncology and Pathology 1 , 2 , and 3"},{"name":"Department of Laboratory Medicine, Karolinska Institute, Stockholm SE-171 77, Sweden 1 , 2 , and 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Dardalhon","sequence":"additional","affiliation":[{"name":"Center for Neurological diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Brauner","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 , 2 , and 3"},{"name":"Department of Oncology and Pathology 1 , 2 , and 3"},{"name":"Department of Laboratory Medicine, Karolinska Institute, Stockholm SE-171 77, Sweden 1 , 2 , and 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Ambrosi","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 , 2 , and 3"},{"name":"Department of Oncology and Pathology 1 , 2 , and 3"},{"name":"Department of Laboratory Medicine, Karolinska Institute, Stockholm SE-171 77, Sweden 1 , 2 , and 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowan","family":"Higgs","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fransisco J.","family":"Quintana","sequence":"additional","affiliation":[{"name":"Center for Neurological diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sj\u00f6strand","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 , 2 , and 3"},{"name":"Department of Oncology and Pathology 1 , 2 , and 3"},{"name":"Department of Laboratory Medicine, Karolinska Institute, Stockholm SE-171 77, Sweden 1 , 2 , and 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija-Leena","family":"Eloranta","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Uppsala University, Uppsala SE-751 05, Sweden 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"N\u00ed Gabhann","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Winqvist","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 , 2 , and 3"},{"name":"Department of Oncology and Pathology 1 , 2 , and 3"},{"name":"Department of Laboratory Medicine, Karolinska Institute, Stockholm SE-171 77, Sweden 1 , 2 , and 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Sundelin","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 , 2 , and 3"},{"name":"Department of Oncology and Pathology 1 , 2 , and 3"},{"name":"Department of Laboratory Medicine, Karolinska Institute, Stockholm SE-171 77, Sweden 1 , 2 , and 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Jefferies","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Rozell","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 , 2 , and 3"},{"name":"Department of Oncology and Pathology 1 , 2 , and 3"},{"name":"Department of Laboratory Medicine, Karolinska Institute, Stockholm SE-171 77, Sweden 1 , 2 , and 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay K.","family":"Kuchroo","sequence":"additional","affiliation":[{"name":"Center for Neurological diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Wahren-Herlenius","sequence":"additional","affiliation":[{"name":"Department of Medicine 1 , 2 , and 3"},{"name":"Department of Oncology and Pathology 1 , 2 , and 3"},{"name":"Department of Laboratory Medicine, Karolinska Institute, Stockholm SE-171 77, Sweden 1 , 2 , and 3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2009,7,27]]},"reference":[{"key":"2023072917273274000_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.coi.2004.09.014","article-title":"The emerging role of interferon in human systemic lupus erythematosus","volume":"16","author":"Baechler","year":"2004","journal-title":"Curr. Opin. Immunol."},{"key":"2023072917273274000_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature."},{"key":"2023072917273274000_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1385\/CRIAI:25:1:89","article-title":"Immunopathogenesis of Sjogren's syndrome","volume":"25","author":"Borchers","year":"2003","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"2023072917273274000_bib4","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys","volume":"181","author":"Crispin","year":"2008","journal-title":"J. Immunol."},{"key":"2023072917273274000_bib5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature."},{"key":"2023072917273274000_bib7","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.4049\/jimmunol.176.10.6277","article-title":"The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death","volume":"176","author":"Espinosa","year":"2006","journal-title":"J. Immunol."},{"key":"2023072917273274000_bib6","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1016\/j.yexcr.2008.09.011","article-title":"The autoantigen Ro52 is an E3 ligase resident in the cytoplasm but enters the nucleus upon cellular exposure to nitric oxide","volume":"314","author":"Espinosa","year":"2008","journal-title":"Exp. Cell Res."},{"key":"2023072917273274000_bib8","first-page":"183","article-title":"The mapping of the human 52-kD Ro\/SSA autoantigen gene to human chromosome 11, and its polymorphisms","volume":"52","author":"Frank","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"2023072917273274000_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ng1782","article-title":"A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus","volume":"38","author":"Graham","year":"2006","journal-title":"Nat. Genet."},{"key":"2023072917273274000_bib11","doi-asserted-by":"crossref","first-page":"33250","DOI":"10.1074\/jbc.M503066200","article-title":"Structural organization and Zn2+-dependent subdomain interactions involving autoantigenic epitopes in the Ring-B-box-coiled-coil (RBCC) region of Ro52","volume":"280","author":"Hennig","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2023072917273274000_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jmb.2008.01.005","article-title":"The fellowship of the RING: the RING-B-box linker region interacts with the RING in TRIM21\/Ro52, contains a native autoantigenic epitope in Sjogren syndrome, and is an integral and conserved region in TRIM proteins","volume":"377","author":"Hennig","year":"2008","journal-title":"J. Mol. Biol."},{"key":"2023072917273274000_bib12","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.181.3.1780","article-title":"The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3","volume":"181","author":"Higgs","year":"2008","journal-title":"J. Immunol."},{"key":"2023072917273274000_bib13","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.4049\/jimmunol.0802755","article-title":"The sequestosome 1\/p62 attenuates cytokine gene expression in activated macrophages by inhibiting IFN regulatory factor 8 and TNF receptor-associated factor 6\/NF-kappaB activity","volume":"182","author":"Kim","year":"2009","journal-title":"J. Immunol."},{"key":"2023072917273274000_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4049\/jimmunol.179.1.26","article-title":"Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages","volume":"179","author":"Kong","year":"2007","journal-title":"J. Immunol."},{"key":"2023072917273274000_bib15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/1529-0131(200103)44:3<638::AID-ANR112>3.0.CO;2-J","article-title":"Polymorphisms of the Ro52 gene associated with anti-Ro 52-kd autoantibodies in patients with primary Sjogren's syndrome","volume":"44","author":"Nakken","year":"2001","journal-title":"Arthritis Rheum."},{"key":"2023072917273274000_bib16","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/art.23214","article-title":"Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren's syndrome: findings in humans and mice","volume":"58","author":"Nguyen","year":"2008","journal-title":"Arthritis Rheum."},{"key":"2023072917273274000_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/gene.2008.94","article-title":"Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogren's syndrome","volume":"10","author":"Nordmark","year":"2009","journal-title":"Genes Immun."},{"key":"2023072917273274000_bib18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.molimm.2005.04.013","article-title":"Structural, functional and immunologic characterization of folded subdomains in the Ro52 protein targeted in Sjogren's syndrome","volume":"43","author":"Ottosson","year":"2006","journal-title":"Mol. Immunol."},{"key":"2023072917273274000_bib19","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1017\/S1462399408000562","article-title":"Targeting of the immune system in systemic lupus erythematosus","volume":"10","author":"Ramanujam","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"2023072917273274000_bib20","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1093\/emboj\/20.9.2140","article-title":"The tripartite motif family identifies cell compartments","volume":"20","author":"Reymond","year":"2001","journal-title":"EMBO J."},{"key":"2023072917273274000_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1365-2567.2002.01417.x","article-title":"The 52 000 MW Ro\/SS-A autoantigen in Sjogren's syndrome\/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures","volume":"106","author":"Rhodes","year":"2002","journal-title":"Immunology."},{"key":"2023072917273274000_bib22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/art.21571","article-title":"The type I interferon system in systemic lupus erythematosus","volume":"54","author":"Ronnblom","year":"2006","journal-title":"Arthritis Rheum."},{"key":"2023072917273274000_bib23","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.4049\/jimmunol.181.4.2898","article-title":"Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18","volume":"181","author":"Sakai","year":"2008","journal-title":"J. Immunol."},{"key":"2023072917273274000_bib24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/428480","article-title":"Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus","volume":"76","author":"Sigurdsson","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"2023072917273274000_bib25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s10875-007-9157-0","article-title":"Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies","volume":"28","author":"Strandberg","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"2023072917273274000_bib26","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1084\/jem.20070600","article-title":"Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus","volume":"204","author":"Wermeling","year":"2007","journal-title":"J. Exp. Med."},{"key":"2023072917273274000_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.clim.2008.01.019","article-title":"Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity","volume":"127","author":"Wong","year":"2008","journal-title":"Clin. Immunol."},{"key":"2023072917273274000_bib28","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.4049\/jimmunol.181.9.6038","article-title":"Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells","volume":"181","author":"Wu","year":"2008","journal-title":"J. Immunol."},{"key":"2023072917273274000_bib29","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.4049\/jimmunol.0803126","article-title":"TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response","volume":"182","author":"Yang","year":"2009","journal-title":"J. Immunol."},{"key":"2023072917273274000_bib30","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.191.6.995","article-title":"Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity","volume":"191","author":"Yokozeki","year":"2000","journal-title":"J. Exp. Med."}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/206\/8\/1661\/1902474\/jem_20090585.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/206\/8\/1661\/1902474\/jem_20090585.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T13:28:45Z","timestamp":1690637325000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/206\/8\/1661\/40397\/Loss-of-the-lupus-autoantigen-Ro52-Trim21-induces"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,27]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8,3]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20090585","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1163198.627987","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1163198.623875","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1163198.626914","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1163198.625020","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1163198.626974","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1163198.624830","asserted-by":"object"}]},"ISSN":["1540-9538","0022-1007"],"issn-type":[{"value":"1540-9538","type":"electronic"},{"value":"0022-1007","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7,27]]}}}